ClinicalTrials.Veeva

Menu

Letrozole Pretreatment With Misoprostol Induction of Abortion in First Trimester Missed Abortion

S

Shereen Rady Abou El-fetouh

Status and phase

Unknown
Phase 4

Conditions

Missed Abortion

Treatments

Drug: placebo
Drug: letrozole

Study type

Interventional

Funder types

Other

Identifiers

NCT04590482
Letrozole /pretreatment

Details and patient eligibility

About

this study will compare the efficacy of using letrozole pre treatment before misoprostol versus using misoprostol only in the induction of first trimester missed abortion.

Full description

Intervention type: drug

Intervention name: letrozole then misoprostol

Description :letrozole 2.5mg twice per day for 2days then misoprostol 800mcg for all patients to induce abortion

Arm group label:study group

Intervention type :drug

Intervention name:placebo then misoprostol

Description : placebo for 2days then 800mcg misoprostol to all patients to induce abortion

Arm group label: control group

Enrollment

110 estimated patients

Sex

Female

Ages

18 to 42 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Maternal age more than 18 years old.
  2. Gestational age less than 13 weeks confirmed by ultrasound scan on day 1 of the study.
  3. Hemoglobin >10 g/dl
  4. Missed abortion

Exclusion criteria

  1. Mullerian Uterine anomalies as septate, bicornuate uterus.

  2. Fibroid uterus.

  3. Coagulopathy.

  4. Medical disorder that contraindicate induction of abortion.

  5. Allergy to misoprostol or letrozole.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

110 participants in 2 patient groups, including a placebo group

letrozole then misoprostol
Experimental group
Description:
description:letrozole 2.5 mg each 12hours for 2 days at home followed by misoprostol 800mcg vaginally at hospital repeated after 4 hours if needed
Treatment:
Drug: letrozole
placebo then misoprostol
Placebo Comparator group
Description:
Description:placebo each 12 hours for 2days at home followed by 800mcg misoprostol vaginally at hospital and repeat dose after 4 hours if needed
Treatment:
Drug: placebo

Trial contacts and locations

0

Loading...

Central trial contact

shereen khedr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems